Brandon Heidinger
Overview
Explore the profile of Brandon Heidinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lapenskie J, Downar J, Wolfe A, Polskaia N, van den Berg K, Watt C, et al.
Ann Palliat Med
. 2025 Feb;
14(1):57-66.
PMID: 39963758
Background: Agitated delirium frequently poses management challenges in palliative care. Interventions are needed to manage delirium yet allow meaningful end-of-life communication. Dexmedetomidine can provide wakeful sedation and may fill this...
2.
Heidinger B, Webber C, Chambaere K, Close E, Deliens L, Onwuteaka-Philipsen B, et al.
JAMA Intern Med
. 2024 Dec;
185(2):235-237.
PMID: 39652339
No abstract available.
3.
McInnis K, Doucet E, Hafizi K, El Amine F, Heidinger B, Cameron J, et al.
Physiol Rep
. 2024 Jun;
12(12):e16085.
PMID: 38924673
Methylphenidate (MPH) has been previously shown to increase resting energy expenditure (REE) in individuals of normal weight; however, the effects on individuals living with obesity are currently unknown. Ten individuals...
4.
Lapenskie J, Anderson K, Lawlor P, Kabir M, Noel C, Heidinger B, et al.
Palliat Med
. 2024 Jan;
38(2):264-271.
PMID: 38229211
Background: Severe grief is highly distressing and prevalent up to 1 year post-death among people bereaved during the first wave of COVID-19, but no study has assessed changes in grief...
5.
Lawlor P, Cohen L, Adeli S, Besserer E, Gratton V, Murphy R, et al.
BMJ Open
. 2023 Sep;
13(9):e075518.
PMID: 37669840
Objective: To compare comorbidities, symptoms and end-of-life (EoL) palliative medication (antisecretories, opioids, antipsychotics and sedatives) use among decedents before and during the COVID-19 pandemic. Design: In a retrospective cohort study,...
6.
Downar J, Parsons H, Cohen L, Besserer E, Adeli S, Gratton V, et al.
Palliat Med
. 2022 Jul;
36(8):1305-1312.
PMID: 35786109
Background: The COVID-19 pandemic has caused millions of deaths worldwide, leading to symptoms of grief among the bereaved. Neither the burden of severe grief nor its predictors are fully known...
7.
Lawlor P, Parsons H, Adeli S, Besserer E, Cohen L, Gratton V, et al.
BMJ Open
. 2022 Jun;
12(6):e062937.
PMID: 35760548
Objective: To compare end-of-life in-person family presence, patient-family communication and healthcare team-family communication encounters in hospitalised decedents before and during the COVID-19 pandemic. Design: In a regional multicentre retrospective cohort...
8.
El Amine F, Heidinger B, Cameron J, Hafizi K, BaniFatemi S, Robaey P, et al.
Can J Physiol Pharmacol
. 2021 Dec;
100(5):432-440.
PMID: 34910595
Olfaction contributes to feeding behaviour and is modulated by changes in dopamine levels. Methylphenidate (MPH) increases brain dopamine levels and has been shown to reduce appetite and promote weight loss...
9.
Mougharbel F, Sampasa-Kanyinga H, Heidinger B, Corace K, Hamilton H, Goldfield G
Front Public Health
. 2021 Jul;
9:680028.
PMID: 34249844
Alcohol consumption and distress have increased among Canadians since the start of the COVID-19 pandemic. We examined whether sociodemographic and COVID-19-related worries are associated with various combinations of alcohol consumption...